catalyst bed, and fluid catalytic cracking (FCC), in which a powdered catalyst is used and the bed is fast moving. Syntower bottoms (STB) is a refinery stream derived from the TCC process. Its manufacture and use as a marine bunker fuel component may result in repeated and prolonged human skin contact. STB is roughly the TCC process equivalent of, and therefore similar in composition to, clarified slurry oil (CSO) which is produced by the FCC process. The broad classes of chemical components present in STB and CSO are listed in Table 1 .
Although there are no data available in the published literature on the systemic toxicity and developmental toxicity of STB in rats, there are data available on complex mixtures of hydrocarbons with similar analytical profiles. Crude oil is toxic to marine mammals (Lipscomb et ai, 1993) and to rat concepti (Khan et ai, 1987; Feuston et ai, 1992) . CSO is systematically toxic (Cruzan et ai, 1986) and developmentally toxic (Feuston et ai, 1989; Hoberman et ai, 1995) when administered dermally to rats. Developmental toxicity has also been demonstrated by the oral route for CSO and STB (Feuston et ai, 1991) . Systemic and developmental toxicity has been demonstrated for complex organic mixtures derived from coal liquefaction when administered via inhalation, oral gavage, and dermal application. These data have been recently reviewed (Chu et ai, 1994) . The chemical composition of these coal-derived complex mixtures (Springer et ai, 1986) is somewhat similar to that of crude oil-derived cracked refinery streams.
STB was tested as part of an internal product stewardship program. To date, 13-16 refinery streams, including 2 crude oils and 2 wastewater sludges, have been tested for systemic and/or developmental toxicity. Aromatic fractions of refinery streams, including 3-to 7-ring polycyclic aromatic compounds (PAC), are carcinogenic (Roy et ai, 1988; Blackburn et ai, 1988) as well as mutagenic (Blackburn et ai, 1984 (Blackburn et ai, , 1986 . A correlation between the results in the Ames test and both PAC concentration and systemic/developmental toxicity has been established and suggests that toxicity may result from the same PAC metabolites responsible for carcinogenic and mutagenic effects (Feuston et ai, 1994a) . General associations between observed adverse effects and (Mackerer and Mehlman, 1989; Feuston et al., 1994a) for these streams, but the individual data were not included. The results of this present investigation contributed toward establishing that relationship. This association has been instrumental in the development of a computerized model that "predicts" systemic and developmental toxicity of dermally applied refinery streams from compositional data (Feuston etal., 1993 (Feuston etal., , 1994b .
MATERIALS AND METHODS

Test Material
STB (CAS No. 64741-62-4) was obtained from a Mobil Oil Corp. refinery.
Chemical Characterization
Two types of chemical characterizations were employed.
Method I. In the first type, individual refinery steams were fractionated by silica gel elution chromatography to determine gravimetrically the amount of nonaromatics and aromatics present. The aromatic fraction was further analyzed by electron impact mass spectrometry (ASTM method D3239-76) to quantitate and identify components based on the number of aromatic rings in their structures (1-to 5-ring PAC) or as S-PAC and unidentified aromatics. Basic nitrogen in the samples was determined using a perchloric acid-potentiometric titration method. Quantitation of total nitrogen in the petroleum products was accomplished by chemiluminescence. Nonbasic nitrogen was estimated by taking the difference between the total nitrogen and basic nitrogen. Field ionization-mass spectrometry (FIMS) was carried out to identify the nonbasic and basic N-PAC present in the samples. Earlier characterization work (e.g., CSO, LCO) utilized capillary gas chromatography-mass spectrometry to identify the N-PAC (Low et al., 1986; Cruzan et ai, 1986) . However, for the present studies, concentrations on nonbasic and basic N-PAC were determined by FIMS and from calculations based on the corresponding nitrogen levels and the average molecular weight composition of the N-PAC types (FIMS analysis). All chemical analyses were carried out at Mobil's Paulsboro Research Laboratory (Analytical Services and Mass Spectrometry Group, Paulsboro, NJ).
Method II. In the second type of characterization, analysis was performed on PAC-enriched dimethyl sulfoxide (DMSO) extracts of the individual refinery streams. PAC were quantified using procedures described in detail by Roy et ai (1985 Roy et ai ( , 1988 . All PAC analyses were carried out at Mobil's Environmental and Health Sciences Laboratory, Analytical Chemistry Group (Princeton, NJ).
The compositions of STB as well as CSO are shown in Table 1 .
Animal Data
These studies were conducted in accordance with the current guidelines for animal welfare (NIH, 1985) .
Systemic toxicity. Male and female Sprague-Dawley rats (TAC:N(SD)-fBR MPF) were obtained from Taconic Farms (Germantown, NY) at approximately 29 days of age. They were acclimated to the testing facility for 2 weeks before a 1-week pretreatment period was initiated The animals were provided Purina Certified Lab Chow ad libitum. Drinking water was provided, ad libitum, by an automatic watering system Animals were housed individually and were maintained in air-conditioned rooms set to maintain 20-22°C, 40-60% relative humidity, and 12-hr light-dark cycles. Each animal was individually identified by a numbered metal ear tag.
Developmental toxicity. Nulliparous female Sprague-Dawley-derived rats (VAF/Plus Cri.CD(SD)BR) were received from Charles River Breeding Laboratories (Kingston, NY) at approximately 9 weeks of age and were bred at 11 weeks of age in a 1:1 ratio to male rats. Females positive for sperm plug and for sperm in the vaginal fluid were considered to be at Day 0 of gestation and were then individually housed. Husbandry conditions were the same as those described for systemic toxicity studies.
Experimental Design
The basic study design has been previously described for systemic and developmental toxicity (Feuston el ai, 1989) studies. Briefly, undiluted (neat) STB was applied on the backs of rats at the following dose levels: systemic toxicity-0, 8, 30, 125, and 500 mg/kg for 13 weeks, 5 days/week; developmental toxicity-0, 8, 30, and 125 mg/kg on Gestation Days 0-19, 4 mg/kg dosed as 8 mg/kg every other day starting on Gestation Day 0, and 500 mg/kg was dosed on Gestation Days 10-12. In all cases, the dose, which was based on the animal's most recently recorded body weight, was applied once daily, except as noted for 4 mg/kg, by volume from a syringe. In no case was the dosing site covered. Elizabethan-type collars were worn to minimize ingestion of the test material. Endpoints of toxicity evaluated included systemic toxicity-body weights, hematology, serum chemistry, organ weights, and pathology (macroscopic and microscopic evaluations); developmental toxicity-maternal: body weight, food consumption (data not presented), serum chemistry (except at 500 mg/kg), and liver and thymus weights; fetal: resorption, anomalous development [gross, skeletal (Inouye, 1976; Kimmel and Trammel, 1981) , and visceral (Wilson, 1965 (Wilson, , 1973 ], and body weights.
In the systemic toxicology study, each group initially started with 10 animals per group. An additional group of 10 control animals was maintained for comparison with data obtained from STB animals that were killed prior to schedule (elective termination). Animals used for subchronic studies were killed by overexposure to carbon dioxide during 1 Animals in this group were previously found dead or euthanized * Significantly different from control (p < 0.01).
• Significantly different from control (p < 0.05).
Week 14 of the study (scheduled termination). Times of elective terminations are noted as applicable. In general, male and female rats exposed to 500 mg/kg were killed during Week 9 of the study, male rats exposed to 125 mg/kg were killed during Week 11, and female rats exposed to 125 mg/kg were killed during Week 13/14. Animals used in the subchronic study were fasted the night prior to Week 5 and 13 clinical chemistry evaluations. Blood was obtained via the orbital sinus while under diethyl ether anesthesia.
Group size for the developmental toxicity evaluations ranged from 11
to 15 pregnant animals. The developmental toxicity screen employed was designed to address employee concerns resulting from exposure to refinery streams, and was mandated by an internal product stewardship program. Since the source of crude oil, as well as its processing, dictates the chemical composition of the resulting complex mixture, the potential number of refinery streams and blends is large. Testing each of these materials for the potential to cause adverse health effects and developmental toxicity becomes impractical and cost prohibitive. In order to test a large number of streams and decrease expenses, fewer than 20 ± 99** ± 0.13 ± 57.7 ± 11.1* 'iV = 8-10 (0 mg/kg), 10 (8 mg/kg): 9-10 (30 mg/kg), 5-6 (125 mg/kg). b Parameters evaluated at Week 11. Animals were not fasted due to debilitated condition. Data were compared to data from "extra" control animals which were euthanized at the same time as STB-exposed animals.
c Values are expressed as the mean ± SD. " Significantly altered at Week 5. * Significantly different from control (p < 0.05).
animals per group were used in the screen This screen has been effective in identifying numerous refinery streams as potential developmental toxicants (Feuston et ai, 1989 (Feuston et ai, , 1994a . Rationale for studies of similar design has been presented elsewhere (Hams et al., 1992; OECD, 1992) . The animals used in this study were killed by exsanguination while anesthetized with diethyl ether on Gestation Day 20. Maternal animals were not fasted prior to clinical chemistry evaluation, samples were obtained on Gestation Day 20 at the time of termination Data were collected, processed and analyzed using computerized data acquisition systems. Body weight data from the systemic toxicity study were analyzed by analysis of variance (ANOVA) and associated F test followed by Dunnett's test, provided that statistical significance was achieved with ANOVA. Hematology and organ weight data were analyzed by ANOVA and associated F test followed by Tukey's multiple comparison test. Clinical chemistry data were analyzed by ANOVA followed by Student-Newman-Keul's test. Data generated in the developmental toxicity study, including maternal body weights and food consumption data, cesarean section data, and fetal body weight data, were analyzed by ANOVA followed by group comparisons using Fisher's exact or Dunnett's test. Fetal gross, visceral, and skeletal data were analyzed by ANOVA followed by Fisher's exact test. Maternal serum chemistry and organ weight (liver and thymus) data were analyzed by ANOVA followed by Tukey's multiple comparison test. Differences between control and treated animals were considered statistically sig- nificant only if the probability of the difference being due to chance was less than 5% (p < 0.05).
RESULTS
Systemic Toxicity
Clinical observations and skin irritation. All of the male rats exposed to 125 and 500 mg/kg STB, and all of the female rats exposed to 500 mg/kg, died or were killed prior to the scheduled necropsy. In addition, eight of the females exposed to 125 mg/kg and two of the male rats exposed to 30 mg/kg died or were killed prior to the scheduled necropsy. During the cause of the study all rats were observed frequently with dry red nasal discharge and occasionally with evidence of chromodacryorrhea; both effects were unrelated to treatment with STB. Clinical signs indicative of systemic toxicity were observed in male rats at dose levels 3=30 mg/ kg and in female rats exposed to 5= 125 mg/kg, and included decreased motor activity, coolness to touch, decreased food consumption, dyspnea, pallor, petechia on skin or mucous membranes, and perinea! staining. There was a general progression over time from observations of dermal petechiae and perineal staining to pallor, coolness to touch, and decreased motor activity, to decreased fecal output and food consumption, and finally to emaciation and death. No evidence that the animals ingested test material was observed.
Minimal skin irritation (flaking) was observed at the exposure site. Control animals exhibited no evidence of systemic toxicity or skin irritation.
Body weights. Mean body weights for select time points are presented in Table 2 . Male and female rats exposed to 125 mg/kg or greater gained significantly less weight than the controls.
Clinical chemistry. Significant decreases in red blood cell count, hemoglobin and hematocrit levels, and platelet count were seen in male and female rats exposed to 30 or 125 mg/kg STB surviving to Week 13 (Table 3) . Some of these effects were seen as early as Week 5. Numerous serum chemistry parameters were also adversely affected in male and/or female rats exposed to 125 mg/kg STB (Tables 4  and 5 ). Animals exposed to STB that were killed prior to scheduled necropsy had aberrant hematology and serum chemistry findings during Week 5 evaluations.
Pathology. Numerous findings were observed at the time of necropsy and included petechia, reddening, pallor and/or edema in various organs, thin whole blood, decreased bone marrow, reduced body fat, enlarged heart, small primary and accessory sex organs, small and/or discolored kidneys, fragile, large, and discolored liver, enlarged lymph nodes, small spleen, and small thymus. At necropsy, no test material was noted in the stomachs of animals exposed to STB. Most of these findings were confirmed by organ weighing and/or histopathological evaluation. Although some of the findings were sporadically observed at 8 mg/ kg, the findings were commonplace at 125 and 500 mg/kg.
Absolute and relative thymus and liver weights data are presented in Table 6 . At 30 mg/kg or greater, the thymus was reduced in size. In general, an increase in relative liver " Body wt gain = Gestation Day (GD) 20 wt -GD 0 wt. Values are expressed as means ± SD. * Net wt gain = (terminal body wt -gravid uterus wt) -GD 0 body wt. 'Syntower bottoms administered GD 0-19, except at 500 mg/kg which was administered on GD 10-12.
•Significantly different from control (p < 0.05). *• Significantly different from control (p < 0.01).
weight was seen in male and female rats dosed at levels as low as 30 mg/kg; an increase in absolute liver weight was seen in female rats at dosages of 125 and 500 mg/kg. Treatment-related and generally dose-related histopathologic changes were observed in bone marrow, heart, kidneys, liver, lymph nodes, skin (treated), spleen, stomach, and thymus. Select microscopic findings are presented in Table 7 .
Developmental Toxicity
Maternal toxicity. Dose-related increases in the number of pregnant animals exhibiting red vaginal discharge occurred in animals exposed to STB at dose levels 3=8 mg/kg. Many of these animals appeared pale during this period. Loose stool was observed primarily in animals exposed to 125 mg/kg; a limited number of occurrences was observed at 8 (1) and 500 (2) mg/kg STB. No other clinical signs of toxicity were observed.
Reductions in body weight gain throughout gestation and net body weight gain occurred at all levels of exposure; a summary of select data is presented in Table 8 . Body weight gain was also decreased in animals exposed to STB at a dose level of 500 mg/kg for Gestation Days 10-12. Thymus weights were significantly reduced and the absolute and/or relative liver weight increased at dose levels in excess of 30 mg/kg (Table 8) . A summary of select serum chemistry data is presented in Table 9 . Numerous serum chemistry parameters were affected by exposure to STB at 3=30 mg/kg. Only the albumin/globulin ratio and inorganic phosphorus level were adversely affected at 8 mg/kg.
Reproductive effects. Reproductive data are summarized in Table 10 . Implantation was not adversely affected by exposure to STB. The number of dams with no viable offspring was increased at dose levels of 30 mg/kg and greater. Litter size was significantly reduced at 8 mg/kg and greater.
Fetal toxicity. Mean fetal body weights were decreased at dose levels of 30 and 500 mg/kg (Table 10 ). The mean number of resorptions/litter was significantly increased at dose levels in excess of 8 mg/kg. Although statistical significance was not achieved, the observed threefold increase in resorptions (mean %) observed at 8 mg/kg is believed to be of biological significance (Table 10 ). In general, fetuses exposed in utero to STB throughout gestation showed evidence of growth retardation, but not of teratogenicity (Table  11) . When the period of exposure was restricted to Gestation Days 10-12 (500 mg/kg), 19% of the fetuses evaluated had cleft palates. The incidences of delays in ossification of various skeletal elements were also significantly increased in fetuses exposed in utero to STB on Gestation Days 10-12.
DISCUSSION
Based on our knowledge of the chemical components of refinery streams and their correlation with toxic effects in rats (Feuston et al., 1994a) , it was not surprising that STB is a systemic and developmental toxicant. Comparable toxic effects have been observed in rats exposed dermally to CSO Feuston et al., 1989) , a refinery stream with an analytical profile that is similar to that of STB (Table  1) . As was observed with CSO, target organs of STB-induced toxicity, based on organ weight and histopathology data, included liver, thymus, and bone marrow.
Nonaromatic components of refinery streams are not readily absorbed through the skin (Low et al., 1986) and, therefore, are not suspect for producing toxic effects. Aromatic components, however, can be absorbed through the skin and their toxic effects have been documented . Dermal application of PAC can produce skin cancer (Bingham et al., 1980; International Agency for Research on Cancer, 1983 , as well as systemic 5.7 ± 0.9 98 ± 71 5.7 ± 0.5 470.0 ± 181.9 17.9 ± 2.5 4 toxicity (Beck et al, 1982) . Statistical analyses of data from systemic and developmental toxicity studies performed on refinery streams applied dermally to rats have demonstrated a relationship between end points used to measure toxicity (e.g., organ weights, serum chemistry parameters, resorptions) and increasing levels of 3-to 5-and 4-to 5-ring polycyclic aromatic hydrocarbons, 3-to 7-ring PAC, sulfurSystemic toxicity was comparable in pregnant and noncontaining PAC, and nonbasic nitrogen-containing PAC pregnant female rats. Although a greater number of serum (Feuston et al., 1994a) . Based on chemical class composition chemistry parameters were affected in pregnant rats than in and modified Ames test results, one would have predicted nonpregnant rats, some of the differences were not indicative that STB would be toxic.
of toxicity, but reflected normal serum chemistry profiles for In the present systemic toxicity study, the most frequent that physiological state (Yang et al., 1988) . Many of the treatment-related finding was acute hemorrhage (petechiae) serum chemistry parameters adversely affected in pregnant seen in a variety of tissues. The skin revealed only slight animals were restricted to groups in which an elevated incichronic changes. Tissues which exhibited primary treatment-dence of resorptions was observed. Animals that had a high related changes included bone marrow, liver, lymph nodes, incidence of resorptions had serum chemistry profiles comand lung; the most serious of these effects were seen in the parable to those of nonpregnant animals (Feuston el al., bone marrow and liver. The severe anemia and thrombocyto-1987). penia and mild leukopenia exhibited by many of the treated In addition to producing maternal toxicity, STB was deanimals are probably a direct result of bone marrow injury, velopmentally toxic as well. When exposure extended Effects seen in the heart, kidney, spleen, adrenal, and stom-throughout most of gestation, adverse developmental effects ach are regarded as largely, or probably compensatory or observed included embryolethality and growth retardation; secondary, due to the severe anemia/thrombocytopenia. The no evidence of teratogenicity was apparent. Not only were liver exhibits both adaptive effects, since the liver is a major these same effects observed when the exposure period was site of PAC metabolism, and toxic effects as demonstrated limited to 3 days (500 mg/kg on Gestation Days 10-12), by histopathologial examination of tissue sections.
but the teratogenic potential of the material was clearly dem- onstrated as well, as evidenced by the occurrence of cleft palate in 19% of the surviving fetuses. Although cleft palate had been observed in one fetus exposed to CSO via dermal application throughout gestation (Feuston et al., 1989) , its occurrence could not be conclusively attributed to exposure to the test material. Exposure of pregnant rats to CSO or STB via gavage on a single day of gestation also produced cleft palate in the developing fetuses (Feuston et al., 1991) . In the present study, consideration must be given to the possibility that the teratogenic potential of STB administered throughout gestation might have been masked by excessive embryolethality. In summary, STB is a potent systemic and developmental toxicant/teratogen. A no observed effect level (NOEL) was not established for systemic toxicity and was less than 8 mg/ kg. Similarly, a NOEL for developmental toxicity could not be established either. Even at 4 mg/kg, STB caused evidence of growth retardation.
